Relationship between antimicrobial use and the highest number of multidrug-resistant-Pseudomonas aeruginosa: a 10-year study
The Journal of Infection in Developing Countries · 2024
DOI: 10.3855/jidc.18400 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, 2024. Verfasst von Vitelhe F de Almeida und 7 weiteren Autor:innen. Beteiligte Einrichtung: Universidade Federal de Uberlândia, Minas Gerais. Institute of Biomedical Sciences, Laboratory of Molecular Microbiology, Uberlândia-Minas Gerais, Br…. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Drug Resistance, Multiple, Bacterial, Pseudomonas Infections, Anti-Bacterial Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de Minas Gerais.
Abstract (Originalsprache)
Introduction
Multi-drug-resistant (MDR) Pseudomonas aeruginosa is a dangerous pathogen causing nosocomial infection, particularly in low- and middle-income countries like Brazil. This retrospective study at a Brazilian university hospital examined the relationship between antimicrobial use and MDR-P. aeruginosa. Methodology: Data was collected from 358 patients with non-repetitive P. aeruginosa infections from 2009 to 2019. Antibiotic use was measured in grams and expressed as defined daily dose (DDD) per 1000 patient-days for meropenem, imipenem, polymyxin, and tigecycline.
Results
Extensively drug-resistant (XDR) P. aeruginosa occurred in 36.1%, and MDR in 32.6% of cases. Risk factors for XDR infection were hospitalization prior to infection (OR = 0.9901), intensive care unit (ICU) admission (OR = 0.4766), previous antibiotic use (OR = 1.4417), and use of cefepime (OR = 0.3883). Over the ten-year period, utilization of the monitored antibiotics increased, and there was a positive correlation between the rise in MDR-P. aeruginosa and the consumption of ceftriaxone, imipenem, meropenem, and polymyxin B. The 30-day mortality rate was 40.0% for all patients and 41.0% for those infected with XDR-P. aeruginosa.
Conclusions
This study highlights the negative impact of the indiscriminate use of antimicrobials, which has led to a significant increase in multidrug-resistant P. aeruginosa strains in hospitals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Universidade Federal de Uberlândia, Minas Gerais. Institute of Biomedical Sciences, Laboratory of Molecular Microbiology, Uberlândia-Minas Gerais, Brazil.
- Clinical Hospital, Federal University of Uberlândia, Uberlândia, Minas Gerais, Brazil.
Förderung
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
Zitieren
APA
Almeida, V. F., Dantas, R. C., Ferreira, M. L., Urzedo, J. E., Almeida Junior, E. R., Royer, S., Gontijo-Filho, P. P., & Ribas, R. M. (2024). Relationship between antimicrobial use and the highest number of multidrug-resistant-Pseudomonas aeruginosa: a 10-year study. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.18400
Vancouver
Almeida VF, Dantas RC, Ferreira ML, Urzedo JE, Almeida Junior ER, Royer S, et al. Relationship between antimicrobial use and the highest number of multidrug-resistant-Pseudomonas aeruginosa: a 10-year study. The Journal of Infection in Developing Countries. 2024. doi:10.3855/jidc.18400
BibTeX
@article{Almeida2024,
author = {Almeida, Vitelhe F de and Dantas, Raquel Cc and Ferreira, Melina L and Urzedo, Jane E and Almeida Junior, Elias R de and Royer, Sabrina and Gontijo-Filho, Paulo P and Ribas, Rosineide M},
title = {Relationship between antimicrobial use and the highest number of multidrug-resistant-Pseudomonas aeruginosa: a 10-year study},
journal = {The Journal of Infection in Developing Countries},
year = {2024},
doi = {10.3855/jidc.18400}
}
EUVIMED